Exicure receives extension to meet Nasdaq listing requirements

Wilmington, Delaware - Biotechnology company Exicure, Inc. (NASDAQ:XCUR) has been granted an extension through December 2, 2026 by Nasdaq to comply with the exchange's minimum stockholders' equity requirement. This was disclosed in a press release on September 10, 2026. The company was initially informed on June 5, 2026 that it had not met Nasdaq Listing Rule 5550(b)(1), which mandates a minimum of $2.5 million in stockholders' equity for listed companies.

Prior to the notification, Exicure also failed to satisfy alternative listing standards based on market value or income. Under the extension, the company must complete compliance initiatives and publicly demonstrate adherence to the equity requirement by December 2. Nasdaq will continue to monitor the company's compliance through its next periodic report.

The extension does not confirm Exicure's regained compliance. If the company fails to meet the extension terms, Nasdaq may issue a written delisting determination, which can be appealed to a Nasdaq Hearings Panel. Exicure aims to strengthen its financial position and maximize asset value through strategic initiatives. This report is AI-generated and reviewed by an editor.